3
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Novel influenza A/H1N1 during pregnancy and lactation: safety of vaccines and drug treatment

&
Pages 169-175 | Published online: 10 Jan 2014

References

  • Kobasa D, Kawaoka Y. Emerging influenza viruses: past and present. Curr. Mol. Med.5(8), 791–803 (2005).
  • Rajagopal S, Treanor J. Pandemic (avian) influenza. Semin. Respir. Crit. Care. Med.28(2), 159–170 (2007).
  • Ong A, Kindhauser M, Smith I et al. A global perspective on avian influenza. Ann. Acad. Med. Singap.37(6), 477–481 (2008).
  • Manzoli L, Salanti G, De Vito C et al. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect. Dis.9(8), 482–492 (2009).
  • Crusat M, de Jong MD. Neuraminidase inhibitors and their role in avian and pandemic influenza. Antivir. Ther.12(4 Pt B), 593–602 (2007).
  • Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA72, 978–980 (1919).
  • Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am. J. Obstet. Gynecol.78, 1172–1175 (1959).
  • Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet374(9688), 451–458 (2009).
  • Ács N, Bánhidy F, Puhó E et al. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res. Part A Clin. Mol. Teratol.73(12), 989–996 (2005).
  • Moretti ME, Bar-Oz B, Fried S et al. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology16(2), 216–219 (2005).
  • Neuzil KM, Reed GW, Mitchel EF et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol.148(11), 1094–1102 (1998).
  • Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ176(4), 463–468 (2007).
  • Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N. Eng. J. Med.361, 1935–1944 (2009).
  • Louie JK, Acosta M, Jamiesen DJ et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Eng. J. Med.362, 27–35 (2010).
  • Kumar A, Zarychanski R, Pinto R et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA302, 1872–1879 (2009).
  • CDC. Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb. Mortal. Wkly Rep.58(39), 1100–1101 (2009).
  • CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb. Mortal. Wkly Rep.58 (RR-8), 1–52 (2009); erratum in: MMWR Morb. Mortal. Wkly Rep.58(32), 896–897 (2009).
  • Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.192(4), 1098–1106 (2005).
  • Pool V, Iskander J. Safety of influenza vaccinaton during pregnancy. Am. J. Obstet. Gynecol.194(4), 1200 (2006).
  • Mak TK, Mangtani P, Leese J et al. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis.8(1), 44–52 (2008).
  • Yamaguchi K, Hisano M, Isojima S et al. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. J. Med. Virol.81(11), 1923–1928 (2009).
  • CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb. Mortal. Wkly Rep.58(RR-10), 1–8 (2009).
  • Tamma PD, Ault KA, del Rio C et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.201(6), 547–552 (2009).
  • Immunization Safety Review Committee. Report of the Institute of Medicine. Immunization Safety Review: Vaccines and Autism. Institute of Medicine, Washington, DC, USA (2004).
  • Pellegrini M, Nicolay U, Lindert K et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine27(49), 6959–6965 (2009).
  • Chan KH, Lam SY, Puthavathana P et al. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. J. Clin. Virol.38(2), 169–171 (2007).
  • CDC. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus – United States, 2009. MMWR Morb. Mortal. Wkly Rep.58(30), 826–829 (2009).
  • Hatchette TF, Bastien N, Berry J et al. The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know. Can. J. Public Health100(3), 204–207 (2009).
  • McGeer AJ. Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin. Infect. Dis.48(Suppl. 1), S14–S19 (2009).
  • Bright RA, Medina MJ, Xu X et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet366(9492), 1175–1181 (2005).
  • CDC. Update: Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb. Mortal. Wkly Rep.58(16), 433–435 (2009).
  • Sheu TG, Deyde VM, Okomo-Adhiambo M et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother.52(9), 3284–3292 (2008).
  • Hurt AC, Holien JK, Barr IG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob. Agents Chemother.53(10), 4433–4440 (2009).
  • Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. Clin. Infect. Dis.48(9), 1254–1256 (2009).
  • White NJ, Webster RG, Govorkova EA et al. What is the optimal therapy for patients with H5N1 influenza? PLoS Med.6(6), e1000091 (2009).
  • Tanaka T, Nakajima K, Murashima A et al. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ181(1–2), 55–58 (2009).
  • Jefferson T, Demicheli V, Di Pietrantonj C et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst. Rev.3, CD001265 (2006).
  • Matheson NJ, Harnden A, Perera R et al. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst. Rev.1, CD002744 (2006).
  • He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin. Pharmacokinet.37(6), 471–484 (1999).
  • Robson R, Buttimore A, Lynn K et al. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant.21(9), 2556–2562 (2006).
  • Worley KC, Roberts SW, Bawdon RE. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect. Dis. Obstet. Gynecol.2008, 927574 (2008).
  • Ward P, Small I, Smith J et al. Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemother.55(Suppl. 1), i5–i21 (2005).
  • Wentges-van Holthe N, van Eijkeren M, van der Laan JW. Oseltamivir and breastfeeding. Int. J. Infect. Dis.12(4), 451 (2008).
  • Cass LMR, Efthymiopoulos C, Bye A. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin. Pharmacokinet.36(Suppl. 1), 1–11 (1999).
  • Freund B, Gravenstein S, Elliott M et al. Zanamivir: a review of clinical safety. Drug Saf.21(4), 267–281 (1999).
  • McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev.19(3), 571–582 (2006).
  • Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am. J. Perinatol.20(8), 405–414 (2003).
  • Bar-Oz B, Bulkowstein M, Benyamini L et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf.26(13), 925–935 (2003).
  • Theiler RN. Evidence-based antimicrobial therapy in pregnancy: long overdue. Clin. Pharmacol. Ther.86, 237–238 (2009).
  • Rebordosa C, Kogevinas M, Horvath-Puho E et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am. J. Obstet. Gynecol.198(2), 178.e1–7 (2008).
  • Räsänen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am. J. Obstet. Gynecol.173(1), 20–25 (1995).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.